发表早期临床试验的障碍:瘤学家的观点
Merel J J Lucassen1, Pedro Bergmann2, Olga Husson1
1Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam 1066CX, The Netherlands.
The oncologist
|April 24, 2025
概括
许多早期临床瘤学试验由于实际,资源,动机和协作障碍而未发表. 解决这些问题对于分享关键研究成果至关重要.
科学领域:
- 在瘤学瘤学.
- 临床试验 临床试验
- 出版道德 出版道德
背景情况:
- 早期临床瘤学研究对于推进癌症研究至关重要.
- 许多早期研究没有发表,这限制了研究结果的传播.
- 这种缺乏出版可以阻碍科学进步,并导致资源浪费.
研究的目的:
- 探索早期临床瘤学研究发表不足的原因.
- 确定研究人员在出版过程中遇到的障碍.
- 收集研究人员对改善出版率的潜在解决方案的见解.
主要方法:
- 对21名研究人员进行了半结构化采访,他们有早期临床瘤学研究经验.
- 采访被分析使用反射主题分析,以确定关键主题和障碍.
- 研究人员来自欧洲,北美,亚洲和大洋洲,提供了不同的观点.
主要成果:
- 研究人员强调,发表早期阶段试验结果的伦理,社会和资源相关重要性.
- 确定的障碍包括实际复杂性,资源不足 (时间,资金,人力),动机有限,利益相关者之间的合作不足.
- 五个关键的利益相关者群体 (期刊编辑,赞助商,调查人员,监管机构,社会) 被确定为改善出版的关键.
结论:
- 显著的障碍阻碍了早期临床试验的出版.
- 承认这些出版挑战是制定有效策略的第一步.
- 改善早期临床试验数据的发布和公开共享对于科学进步和患者利益至关重要.
更多相关视频
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.1K
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
16.3K
相关概念视频
Clinical Trials: Overview
2.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.4K
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Preclinical Development: Overview
4.0K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.0K
Nursing Ethical Principles II
889
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
889
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
